An electroencephalogram (EEG) study of adolescents with autism spectrum disorder (ASD) identified a neural signal that may help explain the variation of how those with ASD perceive or understand the mental states of others (called “Theory of Mind”). Led by Matthew Lerner, PhD, of Stony Brook University, the study is published in Clinical Psychological Science.
0 Comments
Note that some links may require registration or subscription. COVID deaths in Brazil surpassed 500,000, and protesters in more than 20 cities are blaming President Jair Bolsonaro for downplaying the pandemic. (NPR) The more contagious and possibly more deadly Delta variant will “probably” become the dominant strain in the U.S. in the next couple of
0 Comments
After a tweet with an image of brown blood smeared on a piece of gauze caught the attention of thousands on #medtwitter, its author hopes it offered a teachable moment — and potentially made physicians aware of a worrisome trend. In early June, a 13-year-old boy presented to Papa Giovanni XXIII Hospital in Bergamo, Italy,
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. More people need to get vaccinated if the United States wants to prevent the spread of deadly variants this winter, says a top vaccine expert. “Vaccines are our only way out of this,” Paul Offit, MD, a member of the FDA
0 Comments
Understanding cellular metabolism – how a cell uses energy- could be key to treating a wide array of diseases, including vascular diseases and cancer. While many techniques can measure these processes among tens of thousands of cells, researchers have been unable to measure them at the single-cell level. Researchers at the University of Chicago’s Pritzker
0 Comments
According to a recent Finnish study, higher levels of moderate and vigorous physical activity can curb arterial stiffening already in childhood. However, sedentary time or aerobic fitness were not linked to arterial health. The results, based on the ongoing Physical Activity and Nutrition in Children (PANIC) Study conducted at the University of Eastern Finland, were
0 Comments
On average, it takes 17 years for new treatments to reach mainstream clinical practice. That means that when patients see a doctor in 2020, they are often getting guidance from 2003. To put this into perspective, current practices come from a time before the iPhone! But during the pandemic, the speed of changes to medical
0 Comments
A new study from researchers in the United Kingdom has found that the coronavirus may cause long-term brain loss and could be the reason some COVID-19 patients lose their sense of smell and taste.   “In short, the study suggests that there could be some long-term loss of brain tissue from COVID, and that would
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. MEMPHIS, Tennessee (AP) — Many Americans are relaxing precautions taken during the COVID-19 pandemic and resuming everyday activities, even as some worry that coronavirus-related restrictions were hastily lifted, a new poll shows. The poll from The Associated Press-NORC Center for Public
0 Comments
93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against variants “not considered Variants of Concern/Interest” All COVID-19 hospitalizations/death occurred in the placebo group Company to host investor conference call today at 8:30 am ET GAITHERSBURG, Md., June 14, 2021 /PRNewswire/ — Novavax, Inc. (Nasdaq:
0 Comments
Treatment for Molluscum Contagiosum Verrica Pharmaceuticals Announces Extension of FDA Review Period of its NDA for VP-102 for the Treatment of Molluscum Contagiosum WEST CHESTER, PA – May 28, 2021 (GLOBE NEWSWIRE) – Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the
0 Comments
First precision therapy that specifically targets the primary driver of the disease Durable clinical responses, including complete remissions, shown in patients with or without prior treatment Full approval supported by robust efficacy and safety data from two clinical trials — CAMBRIDGE, Mass., June 16, 2021 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that
0 Comments
Cannabidiol (CBD) is a substance found in marijuana plants. There are various CBD health benefits such as treating and alleviating skin conditions like acne, eczema and psoriasis. For those who want to try unconventional skin treatment options, there are a lot of CBD skincare products that are now available. These have numerous skin benefits due to CBD’s anti-inflammatory and antimicrobial properties.  Acne
0 Comments
Poppy Jamie has lived experience of the damage that striving for perfection can do to our wellbeing. Now, she’s taking that knowledge, as well as a mountain of professional know-how on self-acceptance, and sharing it so we can all embrace our wildest, most imperfect selves There are more than a few words I’d love to
0 Comments
There has been much written recently about the increasing demand for gender-affirming services; specifically, surgical procedures. However, transgender and gender diverse people have always existed. So to then have the need for gender-affirming care. For a long time, this need refused to be seen or acknowledged. Medicine as a field and society as a whole
0 Comments
Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the environment, but also typically tend to improve and enhance your garden. Though no one is perfect, and it is near-impossible to practice sustainable garden techniques 100% of the time, any changes
0 Comments
palovarotene Treatment for Fibrodysplasia Ossificans Progressiva Ipsen Confirms U.S. FDA Accepts New Drug Application for Palovarotene as the First Potential Treatment Worldwide for Fibrodysplasia Ossificans Progressiva (FOP) PARIS, FRANCE, 28 May 2021 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that its New Drug Application (NDA) for palovarotene, an oral, investigational, selective RARγ agonist for the
0 Comments